To investigate the prognostic value of multiple genetic alterations, indivi
dual molecular tumor profiles were established in 79 sporadic colorectal ca
rcinomas (41 stage II and 38 stage III). Tumors were analyzed for allelic l
oss (LOH) and genetic instability (MSI) using 14 microsatellites intragenic
to or associated with tumor suppressor or DNA mismatch repair genes. Molec
ular profiling identified tumors with LOH at multiple loci without microsat
ellite instability (MSS), tumors with high levels of LOH and low level micr
osatellite marker instability (MSI-L), and tumors with high levels of MSI (
MSI-H), but rare LOH. K-ras mutations occured more frequently in MSS/MSI-L
carcinomas (26%) than in MSI-H colorectal tumors (10%), the latter showing
a high frequency of TGF beta type II frameshift mutations (82%). Correlatio
n of molecular and clinical data revealed a better prognosis for stage III
tumor patients displaying 5q12 loss rather than retention of heterozygosity
. Thus, molecular profiling allows the identification of new prognostic mar
kers and might facilitate the stratification of colorectal cancer patients.